Rapid and selective depletion of CD4+ T lymphocytes and preferential loss of memory cells on interaction of mononuclear cells with HIV-1 glycoprotein-expressing cells

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 16, Issue 2, 1997, Pages 74-82

  Heinkelein, Martin ^a   Müller, Monika ^a   Kutsch, Olaf ^a   Sopper, Sieghart ^a   Jassoy, Christian ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

CD4+ T helper lymphocyte; Envelope glycoprotein; Flow cytometric analysis; HIV; Memory cell

Indexed keywords

BETA1 INTEGRIN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ARTICLE; CELL INTERACTION; CELL LOSS; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE DEPLETION; MEMORY CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SIGANUS;

EID: 0030697398     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199710010-00002     Document Type: Article

References (38)

1. Levy JA. HIV and the pathogenesis of AIDS. Washington: ASM Press, 1994.
2. Koga Y, Nakamura K, Sasaki M, Kimura G, Nomoto K. The difference in gp160 and gp120 of HIV type 1 in induction of CD4 downregulation precedes single-cell killing. Virology 1994;201: 137-41.
3. Lu YY, Koga Y, Tanaka M, Sasaki G, Kimura G, Nomoto K. Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1. J Virol 1994;68:390-9.
4. Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly R-P, Finkel TH. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 1992;176:1099-106.
5. Lifson JD, Feinberg MB, Reyes GR, et al. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature 1986;323:725-8.
6. Lifson JD, Reyes GR, McGrath MC, Stein BS, Engleman EG. AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science 1986;232:1123-7.
7. Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine WA. Role of HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature 1986;322:470-4.
8. Yoffe B, Lewis DE, Petrie BL, Noonan CA, Melnick JL, Hollinger FB. Fusion as a mediator of cytolysis in mixtures of uninfected CD4+ lymphocytes and cells infected by human immunodeficiency virus. Proc Natl Acad Sci USA 1987;84:1429-33,
9. Heinkelein M, Sopper S, Jassoy C. Contact of human immunodeficiency virus type 1-infected and uninfected CD4+ T lymphocytes is highly cytolytic for both cells. J Virol 1995;69: 6925-31.
10. Laurent-Crawford AG, Krust B, Muller S, et al. The cytopathic effect of HIV is associated with apoptosis. Virology 1991;185: 829-39.
11. Laurent-Crawford AG, Krust B. Rivière Y, et al. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res Hum Retroviruses 1993;9:761-73.
12. Corbeil J, Richman DD. Productive infection and subsequent interaction of CD4- gp120 at the cellular membrane is required for HIV-induced apoptosis of CD4+ T cells. J Gen Virol 1995;76:681-90.
13. Maldarelli F, Sato H. Berthold E, Orenstein J, Martin MA. Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency virus type 1. J Virol 1995;69:6457-65.
14. Nardelli B, Gonzales CJ, Schechter M, Valentine FT. CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells. Proc Natl Acad Sci USA 1995;92:7312-6.
15. Walker BD, Flexner C, Paradis TJ, Fuller TC, Hirsch MS, Schooley RT, Moss B. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science 1988; 240:64-6.
16. Earl PL, Koenig S, Moss B. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. J Virol 1991;65: 31-41.
17. Chesebro B, Wehrly K. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J Virol 1988;62:3779-88.
18. Chaffee S, Leeds JM, Matthews TJ, Weinhold KJ, Skinner M, Bolognesi DP, Hershfield MS. Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines. J Exp Med 1988;168:605-21.
19. Heinkelein M, Schneider-Schaulies J, Walker BD, Jassoy C. Inhibition of cytotoxicity and cytokine release of CD8+ HIV-1-specific cytotoxic T lymphocytes by pentoxifylline. J Acquir Immune Defic Syndr Hum Retroviruses 1995;10:417-24.
20. McCloskey TW, Oyaizu N, Coronesi M, Pahwa S. Use of a flow cytometric assay to quantitate apoptosis in human lymphocytes. Clin Immunol Immunopathol 1994;71:14-8.
21. Lanier LL, Weiss A. Presence of Ti (WT31) negative T lymphocytes in normal blood and thymus. Nature 1986;324:268-70.
22. Johnson VA, Barlow MA, Chou T-C, Fisher RA, Walker BD, Hirsch MS, Schooley RT. Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by recombinant soluble CD4 and 3′-azido-3′-deoxythymidine. J Infect Dis 1989;159:837-44.
23. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
24. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22.
25. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996;271:1582-6.
26. Blattner WA, Reitz M, Mann D, Robert-Guroff M, Matthews T, Bolgnesi D, Waters D. Progression of HIV-1 infection in an HTLV-IIIB infected laboratory worker (LW). Int Conf AIDS 1991: Florence, Italy. W.D.4179:432.
27. Piatak M, Saag MS, Yang LC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-54.
28. Levy JA, Ramachandran B, Barker E, Guthrie J, Elbeik T. Plasma viral load, CD4+ cell counts, and HIV-1 production by cells. Science 1996;271:670-1.
29. Embretson J, Zupancic M, Ribas JL, Burke A, Tenner-Racz K, Racz P, Haase AT. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993;362:359-62.
30. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8.
31. Haase AT, Henry K, Zupancic M, et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 1996;274: 985-9.
32. van Noesel CJ, Gruters RA, Terpstra FG, Schellekens PT, van Lier RA, Miedema F. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. J Clin Invest 1990;86:293-9.
33. Gruters RA, Terpstra FG, De Goede RE, et al. Immunological and virological markers in individuals progressing from seroconversion to AIDS. AIDS 1991;5:837-44.
34. Blatt SP, McCarthy WF, Bucko-Krasnicka B, et al. Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons. J Infect Dis 1995;171: 837-44.
35. Schnittman SM, Lane HC, Greenhouse J, Justement JS, Baseler M, Fauci AS. Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects in infected individuals. Proc Natl Acad Sci USA 1990;87:6058-62.
36. Shearer GM, Clerici M. Early T helper cell defects in HIV infection. AIDS 1991;5:245-53.
37. Yang OO, Kalams SA, Rosenzweig M, Trocha A, Koziel M, Walker BD, Johnson RP. Efficient lysis of HIV-1-infected cells by cytotoxic T lymphocytes. J Virol 1996;70:5799-806.
38. Jassoy C, Walker BD. HIV-specific cytotoxic T lymphocytes and the control of HIV-1 replication. Springer Semin Immunopathol 1997;18:341-54.